1. PRELIMINARY RESULTS FROM AN OPEN‐LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T‐CELL LYMPHOMA. (June 2017) Authors: Witzig, T.; Sokol, L.; Jacobsen, E.; Advani, R.; Mondejar, R.; Piris, M.; Burrows, F.; Melvin, C.; Mishra, V.; Scholz, C.; Gualberto, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗